Possible Role of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Recovery of Post-COVID-19 Anosmia

Overview of attention for article published in Infection and Drug Resistance, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#42 of 2,072)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter: 69 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Nasal delivery as a strategy for the prevention and treatment of COVID-19

Article in Expert Opinion on Drug Delivery (August 2023)

Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out

Article in Diseases (May 2023)

An evidence double standard for pharmacological versus non-pharmacological interventions: Lessons from the COVID-19 pandemic

Article in Contemporary Clinical Trials Communications (March 2023)